1. Home
  2. MRAM vs ACET Comparison

MRAM vs ACET Comparison

Compare MRAM & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Everspin Technologies Inc.

MRAM

Everspin Technologies Inc.

HOLD

Current Price

$30.00

Market Cap

766.7M

Sector

Technology

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$8.78

Market Cap

77.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRAM
ACET
Founded
2008
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
766.7M
77.3M
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
MRAM
ACET
Price
$30.00
$8.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$18.50
$48.33
AVG Volume (30 Days)
6.3M
98.7K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$49,417,000.00
N/A
Revenue This Year
$10.22
N/A
Revenue Next Year
$7.38
N/A
P/E Ratio
N/A
N/A
Revenue Growth
37.51
N/A
52 Week Low
$5.59
$0.46
52 Week High
$51.50
$9.47

Technical Indicators

Market Signals
Indicator
MRAM
ACET
Relative Strength Index (RSI) 55.33 58.89
Support Level $8.48 $7.36
Resistance Level $51.50 N/A
Average True Range (ATR) 5.84 0.58
MACD -1.29 0.09
Stochastic Oscillator 20.70 73.84

Price Performance

Historical Comparison
MRAM
ACET

About MRAM Everspin Technologies Inc.

Everspin Technologies Inc is a manufacturer of Magnetoresistive Random Access Memory (MRAM) technology. The company manufactures MRAM products using both captive and third-party manufacturing capabilities. It purchases industry-standard complementary metal-oxide semiconductor (CMOS) wafers from semiconductor foundries and perform back end of line (BEOL) processing that includes magnetic-bit technology at leased 200mm fabrication facility in Chandler, Arizona. It also manufactures full-flow 300mm CMOS wafers with STT-MRAM magnetic-bit technology integrated in BEOL. The company's customers are in key markets, such as industrial, medical, automotive/transportation, aerospace, and data center.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

Share on Social Networks: